AKT1 and neoplasm: Conversely, miR-126 acts as a tumor suppressor by inhibiting the expression of the PIK3R2 subunit of PI3K, thereby suppressing the PI3K/AKT pathway and reducing cell proliferation (Hu et al., 2021).